Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 28/08/2014 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 22/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 28/08/2014 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 31/03/2023 |
Hyung Kim
BRD | Director/Board Member | 40 | 29/03/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 400K | |
| -2.11% | -1.68% | +44.52% | +95.15% | 66.93B | |
| -0.23% | -4.45% | +30.39% | +73.64% | 61.97B | |
| +1.67% | +2.47% | -11.23% | +388.34% | 28.27B | |
| -1.05% | -4.43% | +30.56% | +10.07% | 24.59B | |
| +0.34% | -6.78% | -7.27% | -17.99% | 24.3B | |
| +0.43% | -3.37% | +14.85% | -19.29% | 19.41B | |
| -3.03% | -2.29% | +185.12% | +334.07% | 16.77B | |
| -1.94% | -4.94% | -5.29% | +495.65% | 14.18B | |
| -2.28% | -4.90% | +43.64% | +155.21% | 13.91B | |
| Average | -3.86% | -3.46% | +36.14% | +168.32% | 30.04B | |
| Weighted average by Cap. | -0.84% | -3.06% | +33.46% | +133.67% |
Employees
-
